| Xiamen University Patent applications |
| Patent application number | Title | Published |
|---|
| 20120077195 | Method for Detecting Variations in Nucleic Acid Sequences - The present invention relates to a method and a kit for detecting nucleic acid sequence variation using melting curve analysis, especially relates to a method and a kit for detecting nucleic acid sequence variation by melting curve analysis using self-quenched probe. Said method provides the characteristics of the self-quenched probe employed, as well as the corresponding nucleic acid amplification conditions, so that the probe can bind to the amplified target sequence, and variations of the target sequence can be detected by melting curve analysis. The present invention also encompasses a kit assembled according to the method described. | 03-29-2012 |
| 20110311522 | MONOCLONAL ANTIBODIES BINDING TO AVIAN INFLUENZA VIRUS SUBTYPE H5 HAEMAGGLUTININ AND USES THEREOF - The present invention provides monoclonal antibodies that bind specifically to H5 subtype avian influenza virus hemagglutinin (HA) proteins, and can block the binding activity of at least 50% of the known monoclonal antibodies to the H5 subtype avian influenza virus hemagglutinin (HA) protein. The monoclonal antibodies can be used for the detection, diagnosis, prevention, and treatment of avian influenza viruses, especially the H5 subtype of avian influenza viruses. The present invention also provides the related hybridoma cell lines, isolated nucleic acid molecules and short peptides, as well as medical composition and medical diagnostic equipment and kit containing the monoclonal antibody. | 12-22-2011 |
| 20110243904 | RNA INTERFERENCE TARGET FOR TREATING AIDS - The present invention relates to RNA interference target sequence targeting HIV for the treatment of AIDS. Based on the target sequence, recombinant expression vectors, packaging vectors and cells were constructed, which express a siRNA and/or a miRNA and/or a ribozyme and/or an antisense oligonucleotide targeting HIV. Also provided is the use of the recombinant expression vectors, packaging vectors and recombinant cells in the manufacture of a medicament for the treatment of AIDS. | 10-06-2011 |
| 20100255021 | TRUNCATED L1 PROTEIN OF HUMAN PAPILLOMAVIRUS TYPE 6 - The invention relates to a truncated L1 protein of the Human Papillomavirus Type 6, a virus-like particle consisting of the protein, a vaccine comprising said virus-like particle, and the use of the vaccine in the prevention of condyloma acuminatum or HPV infections. | 10-07-2010 |
| 20090190286 | Supercapacitor - The present invention provides a supercapacitor comprising: a) a positive electrode member comprising a solid material comprising pores and an electrically conductive current collector element bonded to said positive electrode member, wherein the pores comprise a non-flowing liquid comprising a first redox reagent; b) a negative electrode member comprising a solid material comprising pores and an electrically conductive current collector element bonded to said negative electrode member wherein the pores comprise a non-flowing liquid comprising a second redox reagent; and c) a separator member disposed between the positive electrode member and the negative electrode member, wherein the separator member comprising an ion exchange membrane, wherein the positive electrode member and the negative electrode member are bonded to opposite interface surfaces of the separator member. | 07-30-2009 |
